State Of Alaska, Department Of Revenue Vertex Pharmaceuticals Inc Transaction History
State Of Alaska, Department Of Revenue
- $9.42 Billion
- Q3 2024
A detailed history of State Of Alaska, Department Of Revenue transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 47,975 shares of VRTX stock, worth $22.5 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
47,975
Previous 50,345
4.71%
Holding current value
$22.5 Million
Previous $23.6 Million
5.45%
% of portfolio
0.24%
Previous 0.26%
Shares
29 transactions
Others Institutions Holding VRTX
# of Institutions
1,726Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.6 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.54 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.22 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...